Subgroup analysis.

aAdherence endpoint is proportion of antipsychotic dosages taken over a month assessed by 2 unannounced home-based pill counts 30 days apart at 6 months (possible range 0–1). bWHODAS endpoint is WHO Disability Assessment Schedule 2.0, indicating proportion of loss of functioning at 6 months (possible range 0–1). cCGI endpoint is Clinical Global Impression–Severity assessed at 6 months (possible range 1–7). dAdherence (baseline) is based on medication refill adherence over the past year at baseline: people who collected all 6 refills were considered adherent, and those who missed any of the 6 refills were considered nonadherent.